Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Robinhood Markets, Inc. (HOOD) vs Moderna, Inc. (MRNA) Price & Performance

Robinhood Markets, Inc.Trade
Moderna, Inc.Trade

Price performance (Past 24H)

Key statistics

Robinhood Markets, Inc. vs Moderna, Inc. — how do they compare? Robinhood Markets, Inc. trades at $107.32 (market cap $89.13B), while Moderna, Inc. trades at $60.13 (market cap $23.60B). The key difference: Robinhood Markets, Inc. is far larger — about 3.8× Moderna, Inc.'s market cap, and Moderna, Inc. is trading nearer its 52-week high, Robinhood Markets, Inc. nearer its low. Which is the better fit depends on your goals.

HOODMRNA
Market Cap
$89.13B$23.60B
Sector
TechnologyHealth
52-Week High
$152.46$81.80
52-Week Low
$65.16$22.36
Enterprise Value
$90.33B$19.70B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Robinhood Markets, Inc.

Robinhood Markets (HOOD) trades at $99.41, down 0.55% on the day, with technical indicators showing a bearish short-term trend. The stock has strong fundamentals, including 2025 revenue of $4.47 billion and net income of $1.88 billion, with a net margin of 42.09%. Recent news highlights institutional selling and CFO share disposals, but analyst consensus remains bullish with a $113.21 price target. Cash flow improved significantly in 2025 to $1.20 billion net.

The outlook for HOOD is mixed: strong profitability and growth support upside potential, but near-term technical weakness and insider selling pose risks. Investors should weigh robust financials against market sentiment and competitive pressures in the fintech sector.

Moderna, Inc.

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Robinhood Markets, Inc.

Robinhood Markets, Inc. operates a financial services platform. The Company offers brokerage and cash management applications such as stocks, exchange-traded funds, options, and cryptocurrency. Robinhood Markets serves clients in the United States.

Read more on HOOD

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

Read more on MRNA